An encapsulated breast implant is not inherently dangerous, but it can become a problem depending on how much the surrounding scar tissue tightens. Every breast implant triggers some degree of capsule formation. This is your body’s normal response to a foreign object. The capsule only becomes a concern when it thickens, hardens, and begins squeezing the implant, a condition called capsular contracture. Most people with mild encapsulation never need treatment, while severe cases can cause pain, visible distortion, and may require surgery.
What Encapsulation Actually Is
When any medical device is placed inside the body, your immune system responds by wrapping it in a thin layer of scar tissue. For breast implants, this capsule forms within weeks of surgery and, in healthy cases, stays soft, thin, and flexible. You won’t feel it, and the breast looks and moves naturally. This is Grade I on the Baker scale, the standard classification system surgeons use, and it’s the outcome most people have.
The trouble starts when that capsule keeps thickening. One major contributor appears to be bacterial biofilm, a thin layer of bacteria that can colonize the implant surface during or after surgery. This biofilm doesn’t cause an obvious infection. Instead, it triggers a low-grade inflammatory response that persists for months or years, gradually stimulating more and more scar tissue production. The result is a capsule that contracts around the implant like a shrinking shell.
Grades of Severity
Surgeons grade capsular contracture from I to IV using the Baker scale. It’s worth noting that this scale is somewhat subjective and doesn’t actually measure contraction directly. It reflects the overall firmness, appearance, and symptoms of the breast.
- Grade I: The breast looks and feels normal. The capsule is thin and supple. No treatment needed.
- Grade II: The breast feels slightly firm but still looks normal. Most people at this stage don’t require intervention.
- Grade III: The breast feels noticeably hard and looks visibly distorted. The implant may ride higher or appear misshapen.
- Grade IV: The breast is hard, painful, and obviously deformed. The capsule may become calcified over time. This grade typically requires surgery.
Research on Grade IV capsules has found significantly higher amounts of silicone material within the tissue compared to healthy capsules, and the protective inner lining seen in Grade I capsules is largely absent in severe cases.
How Common Is It?
Estimates vary widely. Some studies report capsular contracture in as few as 3% of patients, while others cite rates as high as 51.7%, depending on the timeframe, implant type, and how broadly “contracture” is defined. The condition most commonly develops within the first year after surgery, though it can appear much later.
Where the incision is made during the original surgery has a significant impact. One study found that patients who received implants through a periareolar incision (around the nipple) had a contracture rate of 23%, compared to just 3% for those with an inframammary incision (under the breast fold). That’s roughly a fivefold increase in risk, likely because the incision path near the nipple exposes the implant to more bacteria from the breast ducts.
Implant placement also matters. Smooth-surface implants placed above the muscle (subfascial plane) carry about four times the contracture risk of textured implants in the same position. However, when placed beneath the muscle, both smooth and textured implants carry similar risk. The muscle layer appears to provide a protective buffer regardless of surface type.
Symptoms Worth Paying Attention To
Mild encapsulation often produces no symptoms at all. As contracture progresses, the first thing most people notice is increasing firmness. The breast may feel tight or unnaturally round, and the implant can shift upward on the chest wall. At more advanced stages, you might experience persistent aching or sharp pain, especially when lying on your side or when the breast is pressed.
Visible changes include asymmetry between the two breasts, a ball-like appearance, and rippling or wrinkling of the skin as the capsule distorts the implant’s shape. In severe cases with calcified capsules, the breast can feel almost rock-hard and may interfere with mammogram readings.
The Rupture Connection
A tight capsule doesn’t necessarily cause an implant to rupture, but the two conditions are closely linked. A ruptured silicone implant can sit undetected for years inside its capsule, a situation called “silent rupture.” It’s often discovered only when a patient undergoes imaging or surgery for something else, including capsular contracture itself.
Interestingly, very tight or calcified capsules can actually make imaging harder to interpret. The deeply folded implant inside a rigid capsule can mimic the appearance of a rupture on ultrasound, leading to false-positive results. Surgeons familiar with this pattern typically recommend surgery in these cases anyway, since the severe contracture alone warrants implant replacement.
When Encapsulation Becomes Dangerous
Standard capsular contracture, even at its most severe, is not life-threatening. It’s painful and disfiguring, but it’s a benign process. The one scenario where encapsulation-related changes can signal something serious is breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system.
BIA-ALCL is not breast cancer. It’s a type of T-cell lymphoma that develops either in the fluid surrounding the implant or within the scar capsule itself. The hallmark symptom is sudden, unexplained swelling of the breast, usually years after implant placement. The fluid collection in BIA-ALCL is typically thick and viscous due to high protein content, and volumes can range from 50 to 1,000 milliliters.
It’s important to understand that benign fluid collections around implants (seromas) are not precursors to BIA-ALCL. Research has shown these are two entirely unrelated processes. A patient with recurrent benign seromas is not at increased risk of developing lymphoma. The conditions are distinguished through specific lab testing of the fluid, particularly looking for a cell surface marker called CD30, which is present in all confirmed BIA-ALCL cases but absent in benign fluid. One study also found that BIA-ALCL specimens had a distinctly different bacterial profile compared to normal contracture capsules, with a high presence of a waterborne bacterium called Ralstonia pickettii.
Treatment Options
Grade I and II contracture generally don’t require treatment. Some surgeons prescribe anti-inflammatory medications after surgery to try to prevent progression. One approach uses a class of drugs that block inflammation-promoting chemicals in the body. In a study of over 1,100 patients, those who took this medication for three months after augmentation had a contracture rate of about 3.3%, compared to 5% in the untreated group. The difference was modest and not statistically significant, so this remains a supplementary strategy rather than a proven prevention method.
For Grade III and IV contracture, surgery is the standard treatment. The two main approaches are capsulotomy (cutting and releasing the capsule to relieve pressure) and capsulectomy (removing the capsule entirely, sometimes with the implant still inside it as a single unit). A meta-analysis comparing the two found that capsulotomy had a slightly lower recurrence rate and fewer surgical complications, though the difference was not statistically significant. Both procedures carry meaningful recurrence rates: about 13 to 23% after capsulotomy and 25 to 53% after capsulectomy.
The one situation where complete capsule removal (en bloc capsulectomy) is universally agreed upon is when BIA-ALCL is suspected or confirmed. In that case, removing the entire capsule intact is considered essential for treatment.
Recurrence After Surgery
One of the frustrating realities of capsular contracture is that it tends to come back, particularly if you choose to have a new implant placed. Recurrence rates after corrective surgery range from roughly 14% to over 50%, depending on the procedure and the study. Factors that improve your odds include switching from above-the-muscle to below-the-muscle placement, using a different implant surface texture, and choosing the inframammary incision site if the original surgery used a periareolar approach.
For patients who develop contracture and decide against replacement, simply removing the implant and capsule resolves the problem permanently. The breast will change in appearance without the implant, but the cycle of scar tissue formation stops entirely.